Stocktoria
Precipio, Inc. PRPO
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2000-07-18
Precipio, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $53.5M | $41.8M | $29.5M | $20.3M | $17.7M |
| Gross profit | $10.7M | $7.6M | $6.0M | $2.5M | $2.4M |
| R&D expense | $1.6M | $1.3M | $1.7M | $1.7M | $1.3M |
| Operating income | -$1.2M | -$4.2M | -$7.6M | -$12.8M | -$9.6M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$363,000 | -$4.3M | — | — | — |
| EPS (diluted) | $-0.23 | $-2.93 | $-4.51 | $-10.73 | $-0.40 |
| Operating cash flow | $685,000 | $439,000 | -$3.6M | -$7.7M | -$6.6M |
| Free cash flow | $359,000 | $216,000 | -$3.7M | -$8.0M | -$7.3M |
| Cash & equivalents | $2.7M | $1.4M | $1.5M | $3.4M | $11.7M |
| Inventory | $935,000 | $724,000 | $384,000 | $708,000 | $564,000 |
| Total assets | $21.3M | $17.0M | $18.1M | $21.5M | $30.4M |
| Total liabilities | $6.8M | $4.9M | $3.7M | $5.1M | $5.8M |
| Shareholders' equity | $14.6M | $12.1M | $14.4M | $16.4M | $24.6M |
Source: SEC EDGAR filings · CIK 0001043961 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.